EUVIMEDEUVIMED entdecken
Crossref

Genetic and pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy

Baicheng Kuang, Mengqin Wang, Hao Yan, Qin Jiang, Zhiheng Wang, Haiqiang Ni, Shuaiheng Hou, Xuan Peng, Shiqi Gu, Yuanyuan Zhao, Tongwen Ou, Nianqiao Gong

Translational Research · 2024-10 · 272 · 162-176

DOI: 10.1016/j.trsl.2024.03.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Research, 2024-10. Verfasst von Baicheng Kuang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ T…. Hauptthemen laut MEDLINE: Reperfusion Injury, X-Box Binding Protein 1, Mitophagy, Mice, Knockout. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Major State Basic Research Development Program of China, Huazhong University of Science and Technology, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia reperfusion (I/R) injury is a common clinical complication. X-box binding protein 1 (XBP1), as a critical regulator of the endoplasmic reticulum stress, has been implicated in a variety of diseases. In this study, we aimed to investigate the effects and the underlying mechanism of XBP1 in the progression of hepatic I/R injury. Hepatocyte-specific XBP1 knockout mice, multiple viral delivery systems and specific pharmacological inhibitors were applied in vivo in a partial hepatic I/R injury mouse model and in vitro in a cell model of hypoxia-reoxygenation (H/R) injury. Mitophagy and autophagic flux were evaluated and fluorescence resonance energy transfer (FRET) as well as immunoprecipitation were performed. The results demonstrated that reperfusion for 6 h represented a critical timepoint in hepatic I/R injury and resulted in significant intracellular mitochondrial dysfunction; led to the breakdown of hepatocytes accompanied by the highest expression levels of XBP1. Hepatocyte-specific XBP1 knockout alleviated hepatic I/R injury via enhanced mitophagy, as demonstrated by the reduction in hepatocellular damage/necrosis and increased expression of mitophagy markers. Mechanistically, XBP1 interacted with FoxO1 directly and catalyzed the ubiquitination of FoxO1 for proteasomal degradation. Targeting XBP1 by genetic or pharmacological techniques potentiated the protein levels of FoxO1, further promoting the activity of the PINK1/Parkin signaling pathway, thus augmenting mitophagy and exerting hepatoprotective effects upon I/R injury. In conclusion, the inhibition of XBP1 potentiated FoxO1-mediated mitophagy in hepatic I/R injury. Specific genetic and pharmacological treatment targeting XBP1 in the perioperative 6 h prior to reperfusion exerted beneficial effects, thus providing a novel therapeutic approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryX-Box Binding Protein 1MitophagyMice, KnockoutForkhead Box Protein O1AnimalsMiceLiverMaleMice, Inbred C57BLHepatocytesHumans

Stichwörter der Autor:innen

FoxO1Hepatic I/R injuryMitochondriaMitophagyXBP1

Substanzen

X-Box Binding Protein 1Forkhead Box Protein O1Xbp1 protein, mouseFoxo1 protein, mouse

Autor:innen und Institutionen

  • Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation of Ministry of Education, National Health Commission an…
  • Department of Cardiothoracic surgery, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei China.
  • Department of Urology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Gastroenterology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei China.
  • Department of Urology, Xuanwu Hospital, Capital Medical University, Beijing, China. Electronic address: outongwen1967@126.com.

Förderung

  • Major State Basic Research Development Program of China
  • Huazhong University of Science and Technology
  • National Natural Science Foundation of China

Zitieren

APA

Kuang, B., Wang, M., Yan, H., Jiang, Q., Wang, Z., Ni, H., Hou, S., Peng, X., Gu, S., Zhao, Y., Ou, T., & Gong, N. (2024). Genetic and pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy. Translational Research, 272, 162-176. https://doi.org/10.1016/j.trsl.2024.03.006

Vancouver

Kuang B, Wang M, Yan H, Jiang Q, Wang Z, Ni H, et al. Genetic and pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy. Translational Research. 2024;272:162-176. doi:10.1016/j.trsl.2024.03.006

BibTeX
@article{Kuang2024,
  author = {Kuang, Baicheng and Wang, Mengqin and Yan, Hao and Jiang, Qin and Wang, Zhiheng and Ni, Haiqiang and Hou, Shuaiheng and Peng, Xuan and Gu, Shiqi and Zhao, Yuanyuan and Ou, Tongwen and Gong, Nianqiao},
  title = {Genetic and pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy},
  journal = {Translational Research},
  year = {2024},
  volume = {272},
  pages = {162--176},
  doi = {10.1016/j.trsl.2024.03.006}
}
Kostenlos starten →